News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1032 results

Fed Circuit reverses Novartis’ drug patent win

US23-06-2022

The US Court of Appeals for the Federal Circuit has held that a patent covering Novartis’ multiple sclerosis drug Gilenya is invalid, potentially opening the floodgates for the introduction of generic versions of the drug.

Teva settles patent dispute with Aurobindo

US13-06-2022

Israel-headquartered Teva has settled its dispute with Indian generic maker Aurobindo over a drug used to treat Huntington’s disease.

Novartis, Dana-Farber seek to bar generic leukaemia drug

US09-06-2022Muireann Bolger

Novartis Pharmaceuticals and the Dana-Farber Cancer Institute have filed two lawsuits to bar generic versions of leukaemia drug, Rydapt.

Senators urge USPTO to curb ‘patent thicket’ abuse

US09-06-2022

A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.

Pfizer sues MSN Labs over Xeljanz generic

US09-06-2022Muireann Bolger

Pfizer has sued MSN Laboratories to prevent the rollout of generic copies of the blockbuster drug Xeljanz, used to treat patients with arthritis.

California judge approves BMS $10.8m settlement

US07-06-2022

A judge at the US District Court for the Northern District of California has granted a motion for preliminary approval of a $10.8 million settlement in an antitrust suit.

BMS says Hengrui’s Abraxane infringes

US13-05-2022Alex Baldwin

A subsidiary of Bristol-Myers Squibb has sued Chinese pharma company Jiangsu Hengrui Pharmaceuticals, alleging that the company’s planned generic of cancer medication Abraxane infringes a patent.

AstraZeneca says Mylan, Kindeva infringe another Symbicort patent

US28-04-2022Alex Baldwin

AstraZeneca filed a patent infringement lawsuit against Mylan Pharmaceuticals and Kindeva Drug Delivery on Tuesday, claiming that their generic asthma Symbicort infringes a brand-new patent that was issued the same day.

BioMarin, MSD sue Aurobindo over rare disease drug

US26-04-2022Muireann Bolger

BioMarin Pharmaceutical and MSD, have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan, used to treat a rare genetic disorder.

Aetna gets antitrust suit moved back to state court

US25-04-2022Alex Baldwin

American health care company Aetna has convinced a California court to transfer its antitrust action claiming that Gilead and other drugmakers used pay-for-delay tactics to maintain high costs of HIV treatments.

Showing 1 to 10 of 1032 results

LSIPR